Atlas Trials

Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit)

Clinical trial NCT02823028 · COMPLETED

Trial details

NCT number
NCT02823028
Sponsor
University of California, Irvine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Smoking Cessation
Start date
2016-10-01
Primary completion
2022-09-01
Enrollment
980

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.